IONQ
IonQ, Inc.
There isn't enough reported data to score IONQ yet.
NVO
Novo Nordisk A/S
NVO's fundamentals are mixed: it turned 15% of its revenue into free cash flow, but its operating margin fell 3 points to 43%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
IONQ Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Weak | |
| Unavailable |
IONQ's revenue is currently healthy, and its profitability is stable, but its cash flow is weak. There isn't enough data to rate its balance sheet.
NVO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Healthy |
NVO's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
IONQ PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 33x | $30.86 | — |
| Cheap | 86x | $80.61 | +161% |
| Fair | 126x | $119 | +285% |
| Expensive | 147x | $138 | +349% |
Historical ranges are pointers, not guarantees.
IONQ has the edge over NVO in the historical PE scenario, which offers more potential upside but is not a forecast.
NVO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 10x | $40.65 | — |
| Cheap | 14x | $53.56 | +32% |
| Fair | 27x | $103 | +154% |
| Expensive | 39x | $152 | +273% |
Historical ranges are pointers, not guarantees.
NVO's PE is 10x, but its earnings don't support one, so it isn't a reliable read right now.
IONQ Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect IONQ's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
NVO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Stable | |
| Growth | |
| Weakening | |
| Limited | |
| Low |
Analysts expect NVO's revenue to grow, but its profitability to weaken. However, they disagree widely on these estimates.
IONQ Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.94 | +$6.31 |
| Q2 2026 | -$3.99 | -$1.96 |
| Q1 2026 | $0.39 | +$1.90 |
| Q4 2025 | -$1.82 | -$0.26 |
| Q3 2025 | -$5.37 | -$4.56 |
| Q2 2025 | -$2.03 | -$1.24 |
| Q1 2025 | -$1.51 | -$0.68 |
| Q4 2024 | -$1.56 | -$0.78 |
IONQ has returned to profit: it earned $0.94 per share over the past year, after losing money the year before.
NVO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $3.89 | +4.9% |
| Q1 2026 | $4.07 | +17% |
| Q4 2025 | $3.42 | +1.8% |
| Q3 2025 | $3.47 | +10% |
| Q2 2025 | $3.71 | +24% |
| Q1 2025 | $3.49 | +18% |
| Q4 2024 | $3.36 | +21% |
| Q3 2024 | $3.15 | +27% |
NVO has the edge over IONQ on earnings, with more consistent year-over-year improvement.
IONQ Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $173.8M | +336% |
| Q2 2026 | $80.1M | +287% |
| Q1 2026 | $64.7M | +755% |
| Q4 2025 | $61.9M | +429% |
| Q3 2025 | $39.9M | +222% |
| Q2 2025 | $20.7M | +82% |
| Q1 2025 | $7.6M | -0.2% |
| Q4 2024 | $11.7M | +92% |
IONQ has the edge over NVO on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -249% | +174 points |
| Q2 2026 | -421% | +355 points |
| Q1 2026 | -420% | +580 points |
| Q4 2025 | -369% | +292 points |
| Q3 2025 | -423% | +5.1 points |
| Q2 2025 | -776% | -346 points |
| Q1 2025 | -1000% | -303 points |
| Q4 2024 | -662% | +230 points |
IONQ's operating margin was −249% last quarter, up 174 points from the same quarter a year ago, near the top of its range since 2021.
NVO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $11.7B | +2.1% |
| Q1 2026 | $14.4B | +24% |
| Q4 2025 | $11.8B | -7.6% |
| Q3 2025 | $11.1B | +5.1% |
| Q2 2025 | $11.4B | +13% |
| Q1 2025 | $11.6B | +19% |
| Q4 2024 | $12.7B | +30% |
| Q3 2024 | $10.6B | +21% |
NVO's revenue is growing: $11.7B last quarter, up 2.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 34% | -9 points |
| Q1 2026 | 62% | +12 points |
| Q4 2025 | 40% | -2.8 points |
| Q3 2025 | 32% | -16 points |
| Q2 2025 | 44% | +5.4 points |
| Q1 2025 | 50% | +1 points |
| Q4 2024 | 43% | +2.2 points |
| Q3 2024 | 47% | +1.6 points |
NVO has the edge over IONQ on profitability, with a higher operating margin.
IONQ Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$331.9M | -$204.7M |
| Q2 2026 | -$114M | -$60.2M |
| Q1 2026 | -$159.4M | -$124.1M |
| Q4 2025 | -$83.3M | -$40.3M |
| Q3 2025 | -$127.2M | -$104.2M |
| Q2 2025 | -$53.8M | -$19.7M |
| Q1 2025 | -$35.3M | -$11.7M |
| Q4 2024 | -$43M | -$9.2M |
IONQ has burned cash in almost every quarter: −$689M over the past year, against −$259M the year before.
NVO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $6.3B | +73% |
| Q1 2026 | $1.8B | +20% |
| Q4 2025 | -$5.4B | -$4.7B |
| Q3 2025 | $4.6B | -2.1% |
| Q2 2025 | $3.6B | -34% |
| Q1 2025 | $1.5B | +89% |
| Q4 2024 | -$632.6M | +$390.5M |
| Q3 2024 | $4.7B | +3.3% |
NVO has the edge over IONQ on cash generation, producing positive trailing cash flow while its opponent burns cash.
IONQ Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +9% | +33.2M shares |
| 1 year | +60% | +150M shares |
| 3 years | +99% | +199M shares |
| 5 years | +108% | +208M shares |
IONQ has 401M diluted shares, up 60% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2021 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
NVO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -12.9M shares |
| 1 year | -0.2% | -11M shares |
| 3 years | -1.5% | -66.8M shares |
| 5 years | -3.8% | -177M shares |
| Available history | -6.5% | -311M shares |
NVO has the edge over IONQ on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $520M |
| Q1 2026 | $356.7M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $206.3M |
| Q4 2024 | $1.1B |
| Q3 2024 | $357.4M |
NVO spent $877M buying back its own shares over the past year, down 48% from the year before.
IONQ Net Leverage
NVO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.7x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.4x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
| Q3 2024 | -0.0x | Very low |
NVO's net debt is less than a year of its operating earnings (EBITDA).
IONQ Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.7 | Neutral |
| Stochastic | 22.3 | Neutral |
IONQ's weekly RSI is 41 (neutral) and its Stochastic is 22 (neutral).
NVO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 27.0 | Neutral |
NVO's weekly RSI is 43 (neutral) and its Stochastic is 27 (neutral).
IONQ PE vs Technology Sector
| Metric | IONQ | Sector median | Relative |
|---|---|---|---|
| PE | 33x | 28x | 18% above |
IONQ is trading at 33x earnings, a 18% premium to the Technology sector's median of 28x, though its earnings don't support one.
NVO PE vs Healthcare Sector
| Metric | NVO | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 26x | 60% below |
| PE % | 6 | 29 | 23 pts below |
NVO has the edge over IONQ on valuation relative to its sector.
IONQ Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $35.7 | 13% below |
| 20 week MA | $38.6 | 20% below |
| 50 week MA | $42.4 | 27% below |
| 100 week MA | $42.2 | 27% below |
| 200 week MA | $26.8 | 15% above |
IONQ has fallen below most of its moving averages, though it's still 15% above its 200-week average.
NVO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $39.2 | 3.7% above |
| 20 week MA | $43.9 | 7.4% below |
| 50 week MA | $45.3 | 10% below |
| 100 week MA | $56.3 | 28% below |
| 200 week MA | $80.7 | 50% below |
NVO has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 50% below its 200-week average.
IONQ Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $11.0 | $17.9 | +62% |
| 2022 | $17.9 | $3.30 | -82% |
| 2023 | $3.30 | $12.4 | +275% |
| 2024 | $12.4 | $45.5 | +267% |
| 2025 | $45.5 | $46.0 | +1.1% |
| 2026 YTD | $46.0 | $30.9 | -33% |
IONQ's yearly returns have swung widely, from +275% in 2023 to −82% in 2022. It's down 33% so far in 2026.
NVO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.1 | $34.7 | +19% |
| 2021 | $34.7 | $54.2 | +56% |
| 2022 | $54.2 | $67.0 | +24% |
| 2023 | $67.0 | $103.5 | +54% |
| 2024 | $103.5 | $87.4 | -16% |
| 2025 | $87.4 | $52.4 | -40% |
| 2026 YTD | $52.4 | $40.7 | -22% |
NVO has the edge over IONQ on returns for 2026, with the stronger performance.